Updated: Nov 14, 2024
The average Relmada Therapeutics stock price target is 15.33 with a max estimate of 23.00 and a min estimate of 10.00
Review Relmada Therapeutics earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: Nov 14, 2024
No Data